Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 3 hours ago

      The partnership is part of Eli Lilly’s effort to address a shortage of a new class of weight loss drugs known as glucagon-like peptide 1s (GLP-1s). This is the same class of drugs the

    • Gateway - Quartz

      Quartz· 7 hours ago

      Nordisk trademarks, to stop them from advertising and selling counterfeits of its semaglutide products. The world’s largest company for diabetes treatments alleges illegal ...

    • Analyst Report: Evotec SE

      Morningstar Research via Yahoo Finance· 8 hours ago

      The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's ...